Referenser till artikeln Njurarna - Funktion och näringsbehov

1) ”Few americans are aware they have chronic kidney disease.” Science Daily, 2004-12-29. http://www.sciencedaily.com/releases/2004/12/041219135823.htm
2) Bjålie, Jan G. Människokroppen. Liber, 1998.
3) Damjanov, I. Pathology for the Health Professions. Elsevier, 2000.
4) Sjukvårdsrådgivningen, ”Njurar och urinvägar / Njurarna”. 2005, http://www.sjukvardsradgivningen.se/artikel.asp?CategoryID=19906
5) Himmelmann, Anders. ”Aldosteron – det bortglömda riskhormonet.” Rapport från Kardiovaskulärt vårmöte 2003, http://www.mediahuset.se/Blodtrycket/bt303/aldosteron.htm
6) B Eliasson, R Eggertsen, G Johannsson. ”Prevalens av hyperaldosteronism hos typ 2 diabetespatienter” – pågående forskningsprojekt vid Uddevalla sjukhus. http://www.fou.nu/is/vgregion/ansokan/11677
7) Gordon, D. R. Et al. ”Role of the Sympathetic Nervous System in Regulating Renin and Aldosterone Production in Man” J Clin Invest. 1967; 46(4): 599–605.
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=442043 <http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=442043>
8) Colussi, G.L. et al. ”Insulin Resistance and Hyperinsulinemia Are Related to Plasma Aldosterone Levels in Hypertensive Patients.”
Diabetes Care, 2007;30(10).
9) Ellison, S. ”Quick Tips for a Healthy Kidney.” http://www.naturalhealthweb.com/articles/ellison2.html
10) Wilhelmsson, P. Näringsmedicinska uppslagsboken. Örtagårdens förlag, 2007:414
11) Ichihara A. et al. ”Effects of magnesium on the renin-angiotensin-aldosterone system in human subjects.” The Journal of laboratory and clinical medicine, 1993; 122(4):432–440.
12) Vree, T.B. et al. ”Effect of urinary pH on the pharmacokinetics of salicylic acid, with its glycine and glucuronide conjugates in human.” Int J Clin Pharmacol Ther. 1994 Oct;32(10):550-8.
13) Fored, M.C. et al. ”Acetaminophen, Aspirin, and Chronic Renal Failure.” The New England Journal of Medicine, 2001;345(20):1801–1808. <http://www.kidney.org/news/newsroom/fs_new/prblmkd&amp;urologd.cfm>
14) Wise, Mike. ”Danger: Regular aspirin or Tylenol can hurt your kidneys as evidenced by professional athletes.” New York Times 2002-01-29.
15) Intervju med naturläkaren Jenna Henderson, 13 juni 2008, http://www.jaredhanson.com/blog/?p=11)
16) Batmanghelidj, F. Din kropp skriker efter vatten. Sorena 2006.)
17) Singh R.B. et al. ”Randomized, Double-blind, Placebo-controlled Trial of Coenzyme Q10 in Patients with End-stage Renal Failure.” Journal of Nutritional and Environmental Medicine 2003;13(1):13–22.
18) Intervju med leg. läkare Sylver Quevedo, docent i medicin & nefrologi vid Duke University, Duke Integrative Medicine Center i Durham samt fakultetsmedlem vid Osher Center California University, USA.)
http://www.revolutionhealth.com/conditions/diabetes/treatments-medications/natural-cures-and-therapies/diabetes-expert-advice)
19) Massachusetts General Hospital. ”Vitamin D Injections May Significantly Improve Survival In Dialysis Patients.” ScienceDaily, http://www.sciencedaily.com
20) Linus Pauling Institute, Micronutrient Information Center: Magnesium http://lpi.oregonstate.edu/infocenter/minerals/magnesium/
21) Linus Pauling Institute, Micronutrient Information Center: Krom. http://lpi.oregonstate.edu/infocenter/minerals/chromium/
22) Cowan, Tom. ”Ask the doctor about gout.” The Weston A. Price Foundation, 2005. http://www.trit.us/askdoctor/gout.html
23) Mercola, J. ”Who Knew Preventing Kidney Stones Was this Easy.” http://articles.mercola.com/sites/articles/archive/2009/06/23/Who-Knew-Preventing-Kidney-Stones-was-This-Easy.aspx
24) University of Michigan Health System. ”Kidney stones in children on the rise, expert says,” ScienceDaily, 2009-05-05. http://www.sciencedaily.com/releases/2009/05/090504211038.htm
25) Rodgers A. ”Effect of cola consumption on urinary biochemical and physicochemical risk factors associated with calcium oxalate urolithiasis.” Urol. Res. 1999;27(1):77–81
26) Blacklock, N. J., "Sucrose and Idiopathic Renal Stone." Nutrition and Health. 1987;5(1–2):9–12.
27) Rattan, V. ”Effect of combined supplementation of magnesium oxide and pyridoxine in calcium-oxalate stone formers.” Urol. Res. 1994; 22(3):161–165.
28) Nishiura, J.L. et al. ”Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients.” Urol. Res. 2004;32(5):362–6.
29) Freitas A.M. et. al. "The effect of Phyllanthus niruri on urinary inhibotors fo calcum oxalate crystallization and other factors associated with renal stone formation.” BJU Int. 2002; 89 (9): 829-34.
30) Schulze, Richard. Common Sense Health and Healing. Natural Healing Publications, 2002.